ASC-H 환자의 p16INK4a 면역세포화학염색 검사의 유용성
The Usefulness of p16INK4a Immunocytochemical Staining in ASC-H Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The grey zone of cervical cytology, and in particular atypical squamous cells, cannot exclude HSIL (ASC-H) causes diagnostic difficulties and increases medical expenses. We analyzed p16INK4a expression in ASC-H liquid-based cytology specimens (LBCS) to develop more effective methods for the management of ASC-H patients. Methods: We carried out p16INK4a immunostaining with 57 LBCS of ASC-H diagnostic categories, all of which were histologically cofirmed and 43 cases of which were compared with the results of a human papillomavirus (HPV) chip test. Results: p16INK4a immunostaining with ASC-H LBCS was positive in 20% (3/15) of cervicitis, 25.0% (3/12) of tissue-low-grade squamous intraepithelial lesion, 75.0% (18/24) of tissue-high grade squamous intraepithelial lesion (HSIL), and 100% (6/6) of invasive cancer cases. The positivity of p16INK4a in LBCS was correlated with higher grade of histologic diagnosis (r=0.578, p=0.000). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of p16INK4a immunostaining for the prediction of tissue-HSIL+ were 80.0%, 77.8%, 80.0%, and 77.8%, respectively. The sensitivity, specificity, PPV, and NPV of p16INK4a immunostaining plus HPV chip test for predicting tissue-HSIL+ were 71.2%, 86.4%, 84.2%, and 79.2%. Conclusions: p16INK4a immunostaining as well as HPV chip testing with remaining LBCS with ASC-H are useful objective markers for the prediction of tissue-HSIL+.
Abstract
Background: The grey zone of cervical cytology, and in particular atypical squamous cells, cannot exclude HSIL (ASC-H) causes diagnostic difficulties and increases medical expenses. We analyzed p16INK4a expression in ASC-H liquid-based cytology specimens (LBCS) to develop more effective methods for the management of ASC-H patients. Methods: We carried out p16INK4a immunostaining with 57 LBCS of ASC-H diagnostic categories, all of which were histologically cofirmed and 43 cases of which were compared with the results of a human papillomavirus (HPV) chip test. Results: p16INK4a immunostaining with ASC-H LBCS was positive in 20% (3/15) of cervicitis, 25.0% (3/12) of tissue-low-grade squamous intraepithelial lesion, 75.0% (18/24) of tissue-high grade squamous intraepithelial lesion (HSIL), and 100% (6/6) of invasive cancer cases. The positivity of p16INK4a in LBCS was correlated with higher grade of histologic diagnosis (r=0.578, p=0.000). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of p16INK4a immunostaining for the prediction of tissue-HSIL+ were 80.0%, 77.8%, 80.0%, and 77.8%, respectively. The sensitivity, specificity, PPV, and NPV of p16INK4a immunostaining plus HPV chip test for predicting tissue-HSIL+ were 71.2%, 86.4%, 84.2%, and 79.2%. Conclusions: p16INK4a immunostaining as well as HPV chip testing with remaining LBCS with ASC-H are useful objective markers for the prediction of tissue-HSIL+.
참고문헌 (30)
- Parkin DM, "Estimates of the worldwide incidence of eighteen major cancers in 1985", Int J Cancer, 54, pp.594~606 (1993)
- Denny L, "The prevention of cervical cancer in developing countries", BJOG, 112, pp.1204~1212 (2005)
- Stoler MH, "Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study", JAMA, 285, pp.1500~1505 (2001)
- 윤혜경, "대한세포병리학회 정도관리 현황 및 결과", 대한세포병리학회지, 19(2), pp.65~71 (2008), 대한세포병리학회
- Bibbo M, "Comprehensive cytopatholgy. 3rd ed", pp.77~90 (2008), Saunders-Elseviser
- Srodon M, "Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results", Cancer, 108, pp.32~38 (2006)
- Sherman ME, "Qualification of ASCUS: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study", Am J Clin Pathol, 116, pp.386~394 (2001)
- Wright TC Jr, "2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests", Am J Obstet Gynecol, 197, pp.346~355 (2007)
- Saqi A, "Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia", Diagn Cytopathol, 27, pp.365~370 (2002)
- Sahebali S, "P16INK4a as an adjunct marker in liquid-based cervical cytology", Int J Cancer, 108, pp.871~876 (2004)
- Yoshida T, "Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions", Cancer, 114, pp.83~88 (2008)
- Juric D, "Liquid-based cytology: new possibilities in the diagnosis of cervical lesions", Coll Antropol, 34, pp.19~24 (2010)
- Reuschenbach M, "Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results", Gynecol Oncol, 119, pp.98~105 (2010)
- Duncan L, "Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance", Cancer, 114, pp.34~48 (2008)
- Guo M, "Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance", Diagn Cytopathol, 39, pp.482~488 (2010)
- Nieh S, "Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix", Gynecol Oncol, 91, pp.201~208 (2003)
- Sung CO, "The use of p16(INK4A) immunocytochemistry in “Atypical squamous cells which cannot exclude HSIL” compared with “Atypical squamous cells of undetermined significance” in liquid-based cervical smears", Diagn Cytopathol, 38, pp.168~171 (2010)
- Ho GY, "Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia", J Natl Cancer Inst, 87, pp.1365~1371 (1995)
- Walboomers JM, "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide", J Pathol, 189, pp.12~19 (1999)
- Bosch FX, "The causal relation between human papillomavirus and cervical cancer", J Clin Pathol, 55, pp.244~265 (2002)
- Bibbo M, "Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens", Acta Cytol, 46, pp.25~29 (2002)
- Muñoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N Engl J Med, 348, pp.518~527 (2003)
- Keating JT, "Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia", Am J Surg Pathol, 25, pp.884~891 (2001)
- Serrano M, "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D", CDK4, 1993, pp.366, 704~707
- Nakao Y, "Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation", Br J Cancer, 75, pp.1410~1416 (1997)
- Sano T, "Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions", Am J Pathol, 153, pp.1741~1748 (1998)
- Stanley MA, "Prognostic factors and new therapeutic approaches to cervical cancer", Virus Res, 89, pp.241~248 (2002)
- Srivastava S, "P16INK4A and MIB-1: an immunohistochemical expression in preneoplasia and neoplasia of the cervix", Indian J Pathol Microbiol, 53, pp.518~524 (2010)
- Agoff SN, "p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types", Mod Pathol, 16, pp.665~673 (2003)
- Klaes R, "Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri", Int J Cancer, 92, pp.276~284 (2001)